OncoSil™ (PANCOSIL)
Locally advanced unresectable pancreatic cancer
Phase 2Active
Key Facts
Indication
Locally advanced unresectable pancreatic cancer
Phase
Phase 2
Status
Active
Company
About OncoSil Medical
OncoSil delivers Ph‑radioactive brachytherapy for pancreatic cancer using ultrasound‑guided Ph‑32 microparticle implants.
View full company profileTherapeutic Areas
Other Locally advanced unresectable pancreatic cancer Drugs
| Drug | Company | Phase |
|---|---|---|
| Padeliporfin VTP | ImPact Biotech | Phase 1 |